Adenosine A2A Receptor (Human) Binding Molecules Screening Assay, HEK293/Adenosine A2A Receptor-based (CAT#: ITS-1122-LX150)

HEK293/Adenosine A2A Receptor (Human)

Human

Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. Adenosine A2a receptor (A2aR or ADORA2A) stably expressed in HEK-293 cells. Which can be used in binding assays and functional assay.

HEK293

Cancer

Oncology

In Vitro Cell Binding Assay

Screening and profiling for Adenosine A2A Receptor (Human) binding molecules (such as anti-Adenosine A2A Receptor antibody, ADC) in a cellular context.

Drug candidates screening and profiling assay as a most important analysis for drug discovery. Creative Biolabs provides In Vitro Adenosine A2A Receptor (Human) Binding Molecules Screening Assay to screen Adenosine A2A Receptor (Human) binding molecules (such as anti-Adenosine A2A Receptor antibody, ADC) by cell-based binding FACS analysis. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.

Cell-based Binding Assay; Drug Screening and Profiling assay

Cell Binding Assay

Screening and profiling Adenosine A2A Receptor (Human) binding molecules (such as anti-Adenosine A2A Receptor antibody, ADC) by cell-based binding FACS analysis.

Creative have developed the stable cell line HEK293/Adenosine A2A Receptor (Human), which is designed for screening and profiling Adenosine A2A Receptor (Human) binding molecules (such as anti-Adenosine A2A Receptor antibody, ADC) by cell-based binding FACS analysis.